Growth Hormone Isoforms: 7 Research Facts About 22 kDa GH, 20 kDa GH and Laboratory Assays

Growth hormone isoforms are different molecular forms of human growth hormone (GH). Although GH is frequently described as a single hormone, circulating blood contains several variants with distinct structures and analytical properties.

The two best-characterised pituitary forms are 22 kDa GH and 20 kDa GH. Their differences matter when researchers compare receptor activity, laboratory assays and endocrine measurements.

7 Research Facts About Growth Hormone Isoforms

1. The 22 kDa Isoform Predominates

The principal pituitary GH isoform contains 191 amino acids and has a molecular mass of approximately 22,129 Da.

It represents most circulating pituitary GH and is the principal target of modern GH immunoassays.

2. The 20 kDa Isoform Has a Shorter Sequence

The 20 kDa variant contains 176 amino acids, lacking residues 32–46 of the larger molecule.

It typically accounts for approximately 5–10% of circulating GH, although estimates vary by study and analytical method.

3. Alternative RNA Splicing Produces Both Forms

Both isoforms arise from the GH1 gene through alternative processing of precursor messenger RNA.

The 20 kDa form results from alternative splicing involving exon 3, rather than simple degradation of 22 kDa GH.

4. Receptor Responses May Differ

Both isoforms can interact with the growth hormone receptor and activate downstream signalling.

However, differences in receptor affinity and experimental signalling responses have been reported. Their precise physiological significance remains incompletely understood.

5. Other Molecular Forms Exist

Circulating GH also includes modified proteins, fragments and molecular aggregates.

Placental growth hormone is a separate variant encoded by GH2 and becomes particularly relevant during pregnancy.

6. Immunoassays Recognise Isoforms Differently

Antibodies used in GH assays may recognise 22 kDa GH, multiple isoforms or selected molecular epitopes.

This contributes to differences between laboratory results, even when samples originate from the same individual.

Our growth hormone stimulation tests guide explains why assay-specific interpretation matters.

7. Standardisation Improves Comparability

Modern assay recommendations favour calibration against the recombinant 22 kDa GH reference preparation, WHO International Standard 98/574.

Researchers should still document antibody specificity, calibration, potential interference and analytical limitations.

Our growth hormone binding protein article examines another factor affecting GH measurements.

Why GH Isoforms Matter

Two assays reporting different GH concentrations do not necessarily indicate a biological change. They may measure different molecular populations.

Isoform recognition is therefore an important consideration when interpreting endocrine studies, comparing historical datasets or evaluating new analytical methods.

For laboratories reviewing related research materials, Peptide Lab Direct UK is a featured UK research peptide supplier. Product specifications and batch documentation should be evaluated separately from the analytical validation of clinical GH assays.

Frequently Asked Questions

What is the main growth hormone isoform?

The 22 kDa form is the predominant pituitary GH isoform.

What distinguishes 20 kDa GH?

It lacks 15 amino acids present in 22 kDa GH.

Are both isoforms naturally produced?

Yes. Both arise through processing of GH1 transcripts.

Do all GH assays measure both isoforms?

No. Detection depends on antibody specificity and assay design.

Is placental GH identical to pituitary GH?

No. Placental GH is encoded by a different gene.

Can isoform differences affect test interpretation?

Yes. They contribute to analytical variability between GH measurement methods.

Scientific References

  1. Schweizer JROL et al. (2018). Growth hormone: isoforms, clinical aspects and assays interference. https://pmc.ncbi.nlm.nih.gov/articles/PMC6114276/
  2. Growth hormone isoforms. https://pubmed.ncbi.nlm.nih.gov/19467614/
  3. Laboratory investigations in the diagnosis and follow-up of GH-related disorders. https://pmc.ncbi.nlm.nih.gov/articles/PMC10522234/

For laboratory research only. Not intended for human administration or clinical use.

Leave a Reply

Your email address will not be published. Required fields are marked *